26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
TriviumVet launch the HALT HCM Study recruiting 300 cats with diagnosed subclinical Hypertrophic Cardiomyopathy (HCM)
25th June
We at TriviumVet are thrilled to announce that the long-awaited HALT HCM Study is now live and recruiting cats in cardiac care centers across the United States! The study was...
TriviumVet's Chief Scientific Officer, Dr. Stuart Fitzgerald appointed to NC State Industry Advisory Council
17th November
We are delighted to congratulate our Chief Scientific Officer, Dr. Stuart Fitzgerald on his appointment to this exciting new advisory council through which he will help to shape...
TriviumVet's Feline Chronic Kidney Disease (CKD) candidate deemed eligible for the Expanded Conditional Approval Pathway by the FDA!
10th October
FDA’s Centre for Veterinary Medicine deems TriviumVet’s feline Chronic Kidney Disease (CKD) therapeutic candidate eligible for the Expanded Conditional Approval pathway
TriviumVet are exhibiting at AAFP 2023!!
6th October
We are delighted to announce that we will be exhibiting at the American Association of Feline Practitioners conference 2023 taking place in Memphis, Tennessee next weekend. This...
Viewpoint With Dennis Quaid
26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
Feline HCM product prevented progression of hypertrophy - Results of the RapaCat Study published in JAVMA
28th July
TriviumVet are proud to announce the publication of the results of the RapaCat Study in the Journal of the American Veterinary Medical Association. This study used our novel,...
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations
28th July
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations You can read the full article below....
Congratulations to NC State’s Olby as she Wins 2023 AVMA Career Achievement in Canine Research Award
18th July
Dr. Olby, is a professor of veterinary neurology and neurosurgery at the North Carolina Veterinary School, she has authored or co-authored more than 200 scientific papers, most...
TriviumVet Sponsor renowned ECVPT European College of Veterinary Pharmacology & Toxicology Event
10th July
It was a busy week last week in TriviumVet as we were delighted to be a sponsor of the European College of Veterinary Pharmacology and Toxicology Cardiorenal Symposium. Our CRA...
After selling two pharma firms, Louise Grubb is preparing for the US launch of a treatment for heart disease in cats
7th July
Check out this July 2023 feature in one of Irelands national papers - The Independent Can you always tell when an animal is in pain? Not always, says Louise Grubb,...
TriviumVet's Chief Scientific Officer, Dr. Stuart Fitzgerald appointed to NC State Industry Advisory Council
17th November
We are delighted to congratulate our Chief Scientific Officer, Dr. Stuart Fitzgerald on his appointment to this exciting new advisory council through which he will help to shape...
TriviumVet's Feline Chronic Kidney Disease (CKD) candidate deemed eligible for the Expanded Conditional Approval Pathway by the FDA!
10th October
FDA’s Centre for Veterinary Medicine deems TriviumVet’s feline Chronic Kidney Disease (CKD) therapeutic candidate eligible for the Expanded Conditional Approval pathway
TriviumVet are exhibiting at AAFP 2023!!
6th October
We are delighted to announce that we will be exhibiting at the American Association of Feline Practitioners conference 2023 taking place in Memphis, Tennessee next weekend. This...
Viewpoint With Dennis Quaid
26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
Feline HCM product prevented progression of hypertrophy - Results of the RapaCat Study published in JAVMA
28th July
TriviumVet are proud to announce the publication of the results of the RapaCat Study in the Journal of the American Veterinary Medical Association. This study used our novel,...
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations
28th July
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations You can read the full article below....
Congratulations to NC State’s Olby as she Wins 2023 AVMA Career Achievement in Canine Research Award
18th July
Dr. Olby, is a professor of veterinary neurology and neurosurgery at the North Carolina Veterinary School, she has authored or co-authored more than 200 scientific papers, most...
TriviumVet Sponsor renowned ECVPT European College of Veterinary Pharmacology & Toxicology Event
10th July
It was a busy week last week in TriviumVet as we were delighted to be a sponsor of the European College of Veterinary Pharmacology and Toxicology Cardiorenal Symposium. Our CRA...
After selling two pharma firms, Louise Grubb is preparing for the US launch of a treatment for heart disease in cats
7th July
Check out this July 2023 feature in one of Irelands national papers - The Independent Can you always tell when an animal is in pain? Not always, says Louise Grubb,...